Author:
Chien Yin-Hsiu,Lee Ni-Chung,Chiang Shu-Chuan,Desnick Robert J.,Hwu Wuh-Liang
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine
Reference28 articles.
1. Desnick RJ, Ioannou YA, Eng CM. (2001) α-Galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease. Vol. III. 8th ed. Scriver CR, Beaudet AL, Sly WS, Valle D, Kinzler KE, Vogelstein B (eds.). New York: McGraw-Hill, pp. 3733–74.
2. Banikazemi M, et al. (2007) Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann. Intern. Med. 146:77–86.
3. Wilcox WR, et al. (2004) Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am. J. Hum. Genet. 75:65–74.
4. Weidemann F, et al. (2003) Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation. 108:1299–301.
5. Hwu WL, et al. (2009) Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献